Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Guraxetan

Guraxetan can be used for the synthesis of antineoplastic lutetium (177Lu) zadavotide Guraxetan[1].

Product Specifications

UNSPSC

12352005

Target

Drug Intermediate

Type

Reference compound

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/guraxetan.html

Solubility

10 mM in DMSO

Smiles

O=C(O)CN1CCN([C@](CCC(C)=O)([H])C(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1

Molecular Formula

C20H34N4O9

Molecular Weight

474.51

References & Citations

[1]International Nonproprietary Names for Pharmaceutical Substances (INN) .

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

RBM15B (Putative RNA-Binding Protein 15B, RNA Binding Motif Protein 15B)
490206 100 µL

RBM15B (Putative RNA-Binding Protein 15B, RNA Binding Motif Protein 15B)

Sign In for Pricing
View Details
NDST3 (N-deacetylase/N-Sulfotransferase (Heparan Glucosaminyl) 3, HSST3, MGC130028, MGC130029)
249193 100 µg

NDST3 (N-deacetylase/N-Sulfotransferase (Heparan Glucosaminyl) 3, HSST3, MGC130028, MGC130029)

Sign In for Pricing
View Details
SDC2 Antibody
MBS9507005-01 0.05 mL

SDC2 Antibody

Sign In for Pricing
View Details
SDC2 Antibody
MBS9507005-02 0.1 mL

SDC2 Antibody

Sign In for Pricing
View Details
SDC2 Antibody
MBS9507005-03 5x 0.1 mL

SDC2 Antibody

Sign In for Pricing
View Details
CCM2 (Malcavernin, Cerebral Cavernous Malformations 2 Protein, C7orf22, PP10187, MGC4067, MGC4607, MGC74868) (MaxLight 550)
124472-ML550 100 µL

CCM2 (Malcavernin, Cerebral Cavernous Malformations 2 Protein, C7orf22, PP10187, MGC4067, MGC4607, MGC74868) (MaxLight 550)

Sign In for Pricing
View Details